Head to head

GentleMax Pro vs Splendor X (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: The catalog lists $69,950 (dealer-described unused 2019 unit with three handpieces) for GentleMax Pro. No new-price range is on file for Splendor X. Check the source notes and request current quotes.
Practice fit: GentleMax Pro: dual-wavelength platform. Splendor X: dual-wavelength laser. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

Dual-wavelength platform

View full device profile →

Device B

Dual-wavelength laser

View full device profile →

Price comparison

Price comparison: Candela GentleMax Pro vs Lumenis Splendor X
Attribute	Candela GentleMax Pro	Lumenis Splendor X
New price range	$69,950 (dealer-described unused 2019 unit with three handpieces)Reported source: Dealer quote · Oct 7, 2026	Not published
Used price reference	28975-67000 (core cluster 37700-57500)Reported source: Used listing · Aug 30, 2026	$70k–$110kSource not documented
Payback calculator	View ROI calculator	View ROI calculator
Next step	Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models. Browse current models

New price range

Candela GentleMax Pro: $69,950 (dealer-described unused 2019 unit with three handpieces)Reported source: Dealer quote · Oct 7, 2026
Lumenis Splendor X: Not published

Used price reference

Candela GentleMax Pro: 28975-67000 (core cluster 37700-57500)Reported source: Used listing · Aug 30, 2026
Lumenis Splendor X: $70k–$110kSource not documented

Payback calculator

Candela GentleMax Pro: View ROI calculator
Lumenis Splendor X: View ROI calculator

Next step

Candela GentleMax Pro

Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models.

Browse current models

Lumenis Splendor X

Supplies & running costs

Supplies & running costs: Candela GentleMax Pro vs Lumenis Splendor X
Attribute	Candela GentleMax Pro	Lumenis Splendor X
Supplies & restrictions	Read supply costs & requirements Budget for DCD cryogen and applicable replacement parts. Current US manufacturer prices for cryogen, distance gauges and flashlamps, and cryogen usage for a specified treatment, have not been verified here. The catalog therefore does not establish a per-treatment cost. Dealer quote · Aug 30, 2026 Supply restrictions: no published lock — no electronic gating documented View running-cost details	Read supply costs & requirements No per-treatment disposable. The recurring cost is wear parts — handpiece lenses, flashlamp, protective windows, ceramic reflector, Nd:YAG and alexandrite rods, fibre window. Current US manufacturer wear-part pricing has not been verified here and the figures previously shown carried no dated source. Dealer quote · Aug 30, 2026 View running-cost details

Supplies & restrictions

Candela GentleMax Pro: Read supply costs & requirements
Budget for DCD cryogen and applicable replacement parts. Current US manufacturer prices for cryogen, distance gauges and flashlamps, and cryogen usage for a specified treatment, have not been verified here. The catalog therefore does not establish a per-treatment cost.
Dealer quote · Aug 30, 2026
Supply restrictions: no published lock — no electronic gating documented
View running-cost details
Lumenis Splendor X: Read supply costs & requirements
No per-treatment disposable. The recurring cost is wear parts — handpiece lenses, flashlamp, protective windows, ceramic reflector, Nd:YAG and alexandrite rods, fibre window. Current US manufacturer wear-part pricing has not been verified here and the figures previously shown carried no dated source.
Dealer quote · Aug 30, 2026
View running-cost details

FDA status & indications

FDA status & indications: Candela GentleMax Pro vs Lumenis Splendor X
Attribute	Candela GentleMax Pro	Lumenis Splendor X
FDA status & indication	FDA record cited — see scopeK140122, K201111 Record scope: Family clearance: K140122 (CANDELA GENTLEMAX FAMILY, Candela Corp., decision 9 May 2014) and K201111 (GentleMax Pro Plus, Candela, decision 26 May 2020, family). Checked 4 Sep 2026. Read FDA indication wording “The GentleMAX Family of Laser Systems is indicated for the following at the specified wavelength: 7S5nm Temporary hair reduction. Stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction isdefined as long-term stable reduction in the number of hairs regrowing after a treatment regime. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types (Fitzpatrick [- VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as pant-wine stains, hemangiomas, telangiectasias) 1064nm Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. Permanent hair reduction isdefined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types Fitzpatrick I-VI including tanned skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangioma, warts, telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafd au ]ait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles. 1064nm Temporary increase of clear nail in patients with onychomycosis (e.g., derniatophytes, Trichophyton rubrum and T. mentagrophytes, and for yeast Candida Albicans, etc.)”	FDA ClearedK241407, K243445 Read FDA indication wording “The Nd:YAG 1064 Laser is intended for: • Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of Pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types, such as Fitzpatrick I-VI, including tanned skin. • Photocoagulation and hemostasis of benign pigmented and vascular lesions such as, but not limited to, port-wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. • Coagulation and hemostasis of soft tissue. • Treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sunspots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for benign pigmented lesions to reduce lesion size, for patients with benign lesions that would potentially benefit from aggressive treatment, and for patients with benign lesions that have not responded to other laser treatments. • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. • Treatment of wrinkles. • Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.). The Alexandrite 755 laser is intended for: • Temporary hair reduction. • Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types, such as Fitzpatrick I – VI, including tanned skin. • Treatment of benign pigmented lesions. • Treatment of wrinkles. • Photocoagulation of dermatological benign vascular lesions (such as port-wine stains, hemangiomas, telangiectasias).”

FDA status & indication

Candela GentleMax Pro: FDA record cited — see scopeK140122, K201111
Record scope: Family clearance: K140122 (CANDELA GENTLEMAX FAMILY, Candela Corp., decision 9 May 2014) and K201111 (GentleMax Pro Plus, Candela, decision 26 May 2020, family). Checked 4 Sep 2026.
Read FDA indication wording
“The GentleMAX Family of Laser Systems is indicated for the following at the specified wavelength: 7S5nm Temporary hair reduction. Stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction isdefined as long-term stable reduction in the number of hairs regrowing after a treatment regime. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types (Fitzpatrick [- VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as pant-wine stains, hemangiomas, telangiectasias) 1064nm Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. Permanent hair reduction isdefined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types Fitzpatrick I-VI including tanned skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangioma, warts, telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafd au ]ait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles. 1064nm Temporary increase of clear nail in patients with onychomycosis (e.g., derniatophytes, Trichophyton rubrum and T. mentagrophytes, and for yeast Candida Albicans, etc.)”
Lumenis Splendor X: FDA ClearedK241407, K243445
Read FDA indication wording
“The Nd:YAG 1064 Laser is intended for: • Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of Pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types, such as Fitzpatrick I-VI, including tanned skin. • Photocoagulation and hemostasis of benign pigmented and vascular lesions such as, but not limited to, port-wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. • Coagulation and hemostasis of soft tissue. • Treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sunspots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for benign pigmented lesions to reduce lesion size, for patients with benign lesions that would potentially benefit from aggressive treatment, and for patients with benign lesions that have not responded to other laser treatments. • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. • Treatment of wrinkles. • Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.). The Alexandrite 755 laser is intended for: • Temporary hair reduction. • Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types, such as Fitzpatrick I – VI, including tanned skin. • Treatment of benign pigmented lesions. • Treatment of wrinkles. • Photocoagulation of dermatological benign vascular lesions (such as port-wine stains, hemangiomas, telangiectasias).”

Which chains run each

Which chains run each: Candela GentleMax Pro vs Lumenis Splendor X
Attribute	Candela GentleMax Pro	Lumenis Splendor X
Chain adoption	3 recorded pairings	0 recorded pairings
Chains using it	Milan Laser Hair Removal(Confirmed) SEV Laser(Confirmed) Body Details(Confirmed)	—
Approved reviews	0	0

Chain adoption

Candela GentleMax Pro: 3 recorded pairings
Lumenis Splendor X: 0 recorded pairings

Chains using it

Candela GentleMax Pro: Milan Laser Hair Removal(Confirmed)
SEV Laser(Confirmed)
Body Details(Confirmed)
Lumenis Splendor X: —

Approved reviews

Candela GentleMax Pro: 0
Lumenis Splendor X: 0

Specs and platform

Specs and platform: Candela GentleMax Pro vs Lumenis Splendor X
Attribute	Candela GentleMax Pro	Lumenis Splendor X
Manufacturer	Candela	Lumenis
Built by (OEM)	Candela Corporation	Lumenis Be Ltd.
Category	Dual-wavelength platform	Dual-wavelength laser
Technology	755nm alex + 1064nm Nd:YAG (Nd:YAG)	755+1064nm BLEND X square spot
Launch year	2013	2018
Status	Discontinued	Current
Manufacturing relationship evidence	No separate manufacturing-relationship record linked.	No separate manufacturing-relationship record linked.

Manufacturer

Candela GentleMax Pro: Candela
Lumenis Splendor X: Lumenis

Built by (OEM)

Candela GentleMax Pro: Candela Corporation
Lumenis Splendor X: Lumenis Be Ltd.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Cutera Excel HR

Dual-wavelength laser

New-equipment price reference

$95k–$135k

Source not documented

Check the profile for configuration and price details.

Lutronic Clarity II

Dual-wavelength laser

New-equipment price not yet documented.

Quanta System Duetto MT / MT Evo

Dual-wavelength laser

New-equipment price not yet documented.

Quanta System Thunder (MT)

Dual-wavelength laser

New-equipment price not yet documented.

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.